Table 4.
Various characteristics of the PPS.
| Characteristic | Number | (%) |
|---|---|---|
| Ten commonest diagnoses treated with antimicrobials | ||
| Pneumonia | 58 | 18.4 |
| Skin and soft tissue | 36 | 11.4 |
| Sepsis | 35 | 11.1 |
| Upper respiratory tract infection | 25 | 7.9 |
| Malaria | 24 | 7.6 |
| Infection of central nervous system | 22 | 7.0 |
| Obstetrics/gynaecology infection | 22 | 7.0 |
| Bone and joint infection | 15 | 4.8 |
| Gastro-intestinal infection | 14 | 4.4 |
| Intra-abdominal sepsis | 10 | 3.2 |
| Treatment according to biomarkers (n = 527) | ||
| No | 502 | 95.3 |
| Yes | 25 | 4.7 |
| Antibiotic quality indicators by department | ||
| Medical | ||
| Reason in notes | 235 | 76.1 |
| Guidelines missing | 79 | 25.6 |
| Guideline compliant | 122 | 85.9 |
| Stop/review date | 119 | 38.5 |
| Surgical | ||
| Reason in notes | 183 | 44.3 |
| Guidelines missing | 127 | 30.8 |
| Guideline compliant | 135 | 83.3 |
| Stop/review date | 206 | 49.9 |
| Intensive care unit | ||
| Reason in notes | 35 | 41.2 |
| Guidelines missing | 11 | 12.9 |
| Guideline compliant | 38 | 92.7 |
| Stop/review date | 10 | 11.8 |
| Patients with isolated multi-drug resistant pathogen | ||
| Third generation cephalosporin resistant (TGCR) | 2 | 4.4 |
| Carbapenem-resistant enterobacteriaceae | 2 | 4.4 |
| Carbapenem-resistant non fermentor Gram-negative bacilli | 2 | 4.4 |
| ESBL-producing Enterobacteriaceae | 7 | 15.6 |
| ESBL-producing Enterobacteriaceae-TGCR | 1 | 2.2 |
| No MDR recorded | 19 | 42.2 |
| Targeted treatment against other MDR organisms | 10 | 22.2 |
| Vancomycin-resistant enterobacteriaceae (VRE) | 2 | 4.4 |